Reserch Development
Quality policy
Drug Safety
Cutaden® Bebe
1. Reference documents
2. Corporate Governance Regulation

Export Brochure 

Quality, safety, health and environmental  policy

Annual Report 2013



December 11 2014 - 59 years of Romanian continuity and performance!
Nowadays, Antibiotice is one of the key drug manufacturers in Romania. Every year new drugs from various therapeutic classes were added to its portfolio so that a balanced product classification was created containing both traditional drugs as well as new generation drugs. 

7.8% increase in gross profit in 2014
The results recorded by Antibiotice at the end of the first nine months of 2014 show an increase in profit and a higher growth rate of the sales in pharmacies (7%) against the  growth rate of the pharmaceutical market in Romania (5.2%)

Antibiotice shares went up 5.5% since early 2015
Antibiotice stock reported a 5.5% rise since the beginning of the current year
Antibiotice is awarded for its export performance
Antibiotice received the Trophy and the Diploma of Honour at the ANEIR Gala held in Bucharest, on 17th December 2014. Prize-winning in six consecutive editions, Antibiotice received this award for its results as the leading exporter of Nystatin.
Copyright 2009 Antibiotice SA Toate drepturile rezervate